Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-resistance by Feature Extraction of Gray Level Co-occurrence Matrix Using Optical Images

Identification of Human Ovarian Adenocarcinoma Cells with Cisplatin-resistance by Feature Extraction of Gray Level Co-occurrence Matrix Using Optical Images

Ovarian cancer is the most malignant of all gynecological cancers. A challenge that deteriorates with ovarian adenocarcinoma in neoplastic disease patients has been associated with the chemoresistance of cancer cells. Cisplatin (CP) belongs to the first-line chemotherapeutic agents and it would be b...

Full description

Bibliographic Details
Main Authors:	Chih-Ling Huang, Meng-Jia Lian, Yi-Hsuan Wu, Wei-Ming Chen, Wen-Tai Chiu
Format:	Article
Language:	English
Published:	MDPI AG 2020-06-01
Series:	Diagnostics
Subjects:	chemoresistance cisplatin gray-level co-occurrence matrix ovarian adenocarcinoma
Online Access:	https://www.mdpi.com/2075-4418/10/6/389

Similar Items

Identification of Bamboo Species Based on Leaf Texture using Gray Level Co-Occurrence Matrix and Gray Level Run Length Matrix
by: Endina Putri Purwandari, et al.
Published: (2018-10-01)

A Method for the Estimation of the Square Size in the Chessboard Image using Gray-level Co-occurrence Matrix
by: Xu Guan, et al.
Published: (2012-01-01)

A Multichannel Gray Level Co-Occurrence Matrix for Multi/Hyperspectral Image Texture Representation
by: Xin Huang, et al.
Published: (2014-09-01)

The Role of Hexokinase II in the Regulation of Glycolysis and Cisplatin Sensitivity in Ovarian Cancer
by: Han, Chae Young
Published: (2018)

Computation of Gray Level Co-Occurrence Matrix Based on CUDA and Optimization for Medical Computer Vision Application
by: Huichao Hong, et al.
Published: (2018-01-01)

Use of a gray level co-occurrence matrix to characterize duplex stainless steel phases microstructure
by: L. Zortea, et al.
Published: (2011-04-01)

Improved Prediction of Protein-Protein Interactions Using Descriptors Derived From PSSM via Gray Level Co-Occurrence Matrix
by: Hui-Juan Zhu, et al.
Published: (2019-01-01)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
by: Wenyu Wang, et al.
Published: (2020-11-01)

Recognition of breast tumor based on gray level co-occurrence matrix and BP neural network
by: Nie Xiong, et al.
Published: (2019-07-01)

Brain Tumor Classification Using Gray Level Co-occurrence Matrix and Convolutional Neural Network
by: Wijang Widhiarso, et al.
Published: (2018-10-01)

High Expression of Nuclear Transcription Factor-κB is Associated with Cisplatin Resistance and Prognosis for Ovarian Cancer
by: Kan Y, et al.
Published: (2020-09-01)

Chinese fingerspelling recognition via gray-level co-occurrence matrix and fuzzy support vector machine
by: Yalan Gao, et al.
Published: (2021-02-01)

Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model
by: Yooyoung Lee, et al.
Published: (2018-07-01)

Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo
by: Chanjuan Li, et al.
Published: (2016-06-01)

Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies
by: Kathleen Wantoch von Rekowski, et al.
Published: (2020-12-01)

Morphological Arrhythmia Automated Diagnosis Method Using Gray-Level Co-Occurrence Matrix Enhanced Convolutional Neural Network
by: Weifang Sun, et al.
Published: (2019-01-01)

Restoration of Motion Blurred Images Based on Rich Edge Region Extraction Using a Gray-Level Co-Occurrence Matrix
by: Minghua Zhao, et al.
Published: (2018-01-01)

Partial Discharge Pattern Recognition of Transformers Based on the Gray-Level Co-Occurrence Matrix of Optimal Parameters
by: Shengya Sun, et al.
Published: (2021-01-01)

Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines <it>in vitro</it> and with lower tumour grade in mucinous ovarian cancers
by: Saran Uttara, et al.
Published: (2012-10-01)

Efficient CU and PU Decision Based on Neural Network and Gray Level Co-Occurrence Matrix for Intra Prediction of Screen Content Coding
by: Chao Huang, et al.
Published: (2018-01-01)

Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP)
by: Chanjuan Li, et al.
Published: (2016-08-01)

Quantitative Analysis of Melanosis Coli Colonic Mucosa Using Textural Patterns
by: Chung-Ming Lo, et al.
Published: (2020-01-01)

Emerging role of long non-coding RNAs in cisplatin resistance
by: Hu Y, et al.
Published: (2018-05-01)

Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells
by: Chien-Hui Weng, et al.
Published: (2020-10-01)

BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
by: Jinghui Jia, et al.
Published: (2020-08-01)

Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells
by: Miguel Angel Merlos Rodrigo, et al.
Published: (2019-03-01)

Radiomic Immunophenotyping of GSEA-Assessed Immunophenotypes of Glioblastoma and Its Implications for Prognosis: A Feasibility Study
by: Justin Bo-Kai Hsu, et al.
Published: (2020-10-01)

Interaction of Adenosine, Modified Using Carborane Clusters, with Ovarian Cancer Cells: A New Anticancer Approach against Chemoresistance
by: Katarzyna Bednarska-Szczepaniak, et al.
Published: (2021-07-01)

Identification of Mutations Related to Cisplatin-Resistance and Prognosis of Patients With Lung Adenocarcinoma
by: Rui Li, et al.
Published: (2020-10-01)

VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin
by: Zhen Liu, et al.
Published: (2021-05-01)

Potential of Texture Analysis for Charcoal Classification
by: Bruno Geike de Andrade, et al.

Immunospecific albumin microspheres as a drug delivery system for cisplatin and 5-fluorouracil for the treatment of ovarian adenocarcinoma
by: Truter, Ernest John
Published: (2017)

Ovarian preservation in adenocarcinoma of the uterine cervix
by: Jiansong Zhou, et al.
Published: (2017-07-01)

A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy
by: Shunsuke Owa, et al.
Published: (2021-09-01)

Reversible Video Steganografi Menggunakan Metode Improved Reduced Difference Expansion dan Analisis Gray Level Co-occurrence Matrix
by: Dicky Irwanto, et al.
Published: (2017-01-01)

Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells
by: Li Liu, et al.
Published: (2019-07-01)

Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
by: Yi-Hui Wu, et al.
Published: (2020-03-01)

Application of Haralick texture features in brain [18F]-florbetapir positron emission tomography without reference region normalization
by: Campbell DL, et al.
Published: (2017-12-01)

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
by: Bo Zhou, et al.
Published: (2019-11-01)